APAC Natural Killer (Nk) Cell Therapeutics Market - Industry Trends And Forecast To 2029
Asia-Pacific natural killer (NK) cell therapeutics market is projected to register a CAGR of 43.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029
Market Segmentation
Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others), Country (Japan, China, Australia, South Korea, India, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific natural killer (NK) cell therapeutics market are:
• Increase in patient population with chronic diseases
• Increasing investment in research and development
• Increase in usage of natural killer (NK) cells for the treatment of cancer and infectious diseases
Market Players
The key market players for Asia-Pacific natural killer (NK) cell therapeutics market are listed below:
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Company Profiles
• Merck KGaA
• Bristol-Myers Squibb Company
• Glycostem
• Kiadis Pharma
• Cytovia Therapeutics
• Nkarta, Inc.
• Nektar
• ImmunityBio, Inc.
• Brink Biologics, Inc.
• Biohaven Pharmaceuticals
• Fate Therapeutics
• EMERcell
• Phio Pharmaceuticals
• PersonGen BioTherapeutics
• Innate Pharma, Inc.
• INmuneBIO
• Gamida Cell
• Acepodia Inc.
• Affimed GmbH
• Multimmune GmbH
• iCell Gene Therapeutics
• Takeda Pharmaceutical Company Limited
• Regeneron Pharmaceuticals Inc.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Asia Pacific Natural Killer (Nk) Cell Therapeutics Market
- 1.4 Limitations
- 1.5 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Multivariate Modelling
- 2.7 Therapeutics Lifeline Curve
- 2.8 Primary Interviews With Key Opinion Leaders
- 2.9 Dbmr Market Position Grid
- 2.10 Secondary Sources
- 2.11 Assumptions
- 3 Executive Summary
- 3.1 Epidemiology
- 3.2 Pestel Analysis
- 3.3 Porter’s Five Forces Model
- 3.4 Industrial Insights:
- 3.5 Pipeline Analysis
- 4 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Regulations
- 5 Market Overview
- 5.1 Drivers
- 5.1.1 Increase In Usage Of Natural Killer (Nk) Cells For The Treatment Of Cancer And Infectious Diseases
- 5.1.2 Increase In Patient Population With Chronic Diseases
- 5.1.3 Rise In Awareness About Immunotherapies
- 5.1.4 Adoption Of Natural Killer (Nk) Cell Therapy In Emerging Markets
- 5.2 Restraints
- 5.2.1 Lack Of Specificity And Poor In-vivo Survival Of The Cells
- 5.2.2 Adverse Side Effects Of Therapies
- 5.2.3 High Cost Associated With The Therapies
- 5.3 Opportunities
- 5.3.1 Advancement In Natural Killer (Nk) Cell Therapies
- 5.3.2 Strategic Initiatives By Market Players
- 5.3.3 Rise In Expenditure In Healthcare Sector
- 5.4 Challenges
- 5.4.1 Long Approval Time For Immunotherapies
- 5.4.2 Lack Of Specific Treatment By Natural Killer (Nk) Cells
- 5.4.3 Availability Of Alternatives For Tumor Treatment
- 6 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics
- 6.1 Overview
- 6.2 Nk Cell Therapies
- 6.3 Nk Cell Directed Antibodies
- 7 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Approaches
- 7.1 Overview
- 7.2 Antibody-dependent Cell-mediated Cytotoxicity (Adcc)
- 7.3 Bispecific Antibodies
- 8 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Application
- 8.1 Overview
- 8.2 Cancer
- 8.2.1 Solid Tumors
- 8.2.2 Hematologic Malignancies
- 8.2.2.1 Multiple Myeloma
- 8.2.2.2 Acute Myeloid Leukemia (Aml)
- 8.2.2.3 Lymphoma
- 8.2.2.4 Others
- 8.2.3 Others
- 8.3 Immunoproliferative Disorders
- 8.4 Acute Infectious Diseases
- 8.5 Gastrointestinal Diseases
- 8.6 Others
- 9 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By End User
- 9.1 Overview
- 9.2 Hospitals
- 9.3 Specialty Clinics
- 9.4 Research & Academic Institutes
- 10 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel
- 10.1 Overview
- 10.2 Hospital Pharmacies
- 10.3 Direct Tender
- 10.4 Others
- 11 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Region
- 11.1 Asia-pacific
- 11.1.1 Japan
- 11.1.2 China
- 11.1.3 Australia
- 11.1.4 South Korea
- 11.1.5 India
- 11.1.6 Singapore
- 11.1.7 Malaysia
- 11.1.8 Thailand
- 11.1.9 Indonesia
- 11.1.10 Philippines
- 11.1.11 Vietnam
- 11.1.12 Rest Of Asia-pacific
- 12 Asia Pacific Natural Killer (Nk) Cells Therapeutics Market, Company Landscape
- 12.1 Company Share Analysis: Asia Pacific
- 13 Swot Analysis
- 14 Company Profile
- 14.1 Merck Kgaa
- 14.1.1 Company Snapshot
- 14.1.2 Recent Financials
- 14.1.3 Product Portfolio
- 14.1.4 Recent Developments
- 14.2 Bristol-myers Squibb Company
- 14.2.1 Company Snapshot
- 14.2.2 Recent Financials
- 14.2.3 Product Portfolio
- 14.2.4 Recent Developments
- 14.3 Glycostem
- 14.3.1 Company Snapshot
- 14.3.2 Product Portfolio
- 14.3.3 Recent Developments
- 14.4 Innate Pharma, Inc.
- 14.4.1 Company Snapshot
- 14.4.2 Revenue Analysis
- 14.4.3 Product Portfolio
- 14.4.4 Recent Developments
- 14.5 Regeneron Pharmaceuticals Inc.
- 14.5.1 Company Snapshot
- 14.5.2 Recent Financials
- 14.5.3 Product Portfolio
- 14.5.4 Recent Developments
- 14.6 Takeda Pharmaceutical Company Limited
- 14.6.1 Company Snapshot
- 14.6.2 Recent Financials
- 14.6.3 Product Portfolio
- 14.6.4 Recent Developments
- 14.7 Inmunebio
- 14.7.1 Company Snapshot
- 14.7.2 Revenue Analysis
- 14.7.3 Product Portfolio
- 14.7.4 Recent Developments
- 14.8 Kiadis Pharma
- 14.8.1 Company Snapshot
- 14.8.2 Revenue Analysis
- 14.8.3 Product Portfolio
- 14.8.4 Recent Developments
- 14.9 Acepodia Inc.
- 14.9.1 Company Snapshot
- 14.9.2 Product Portfolio
- 14.9.3 Recent Developments
- 14.10 Affimed Gmbh
- 14.10.1 Company Snapshot
- 14.10.2 Recent Financials
- 14.10.3 Product Portfolio
- 14.10.4 Recent Developments
- 14.11 Biohaven Pharmaceuticals
- 14.11.1 Company Snapshot
- 14.11.2 Revenue Analysis
- 14.11.3 Product Portfolio
- 14.11.4 Recent Developments
- 14.12 Brink Biologics, Inc.
- 14.12.1 Company Snapshot
- 14.12.2 Product Portfolio
- 14.12.3 Recent Development
- 14.13 Cytovia Therapeutics
- 14.13.1 Company Snapshot
- 14.13.2 Product Portfolio
- 14.13.3 Recent Developments
- 14.14 Emercell
- 14.14.1 Company Snapshot
- 14.14.2 Product Portfolio
- 14.14.3 Recent Developments
- 14.15 Fate Therapeutics
- 14.15.1 Company Snapshot
- 14.15.2 Revenue Analysis
- 14.15.3 Product Portfolio
- 14.15.4 Recent Developments
- 14.16 Gamida Cell
- 14.16.1 Company Snapshot
- 14.16.2 Product Portfolio
- 14.16.3 Recent Developments
- 14.17 Icell Gene Therapeutics
- 14.17.1 Company Snapshot
- 14.17.2 Product Portfolio
- 14.17.3 Recent Development
- 14.18 Immunitybio, Inc.
- 14.18.1 Company Snapshot
- 14.18.2 Revenue Analysis
- 14.18.3 Product Portfolio
- 14.18.4 Recent Developments
- 14.19 Multimmune Gmbh
- 14.19.1 Company Snapshot
- 14.19.2 Product Portfolio
- 14.19.3 Recent Developments
- 14.20 Nektar
- 14.20.1 Company Snapshot
- 14.20.2 Revenue Analysis
- 14.20.3 Product Portfolio
- 14.20.4 Recent Developments
- 14.21 Nkarta, Inc.
- 14.21.1 Company Snapshot
- 14.21.2 Product Portfolio
- 14.21.3 Recent Developments
- 14.22 Persongen Biotherapeutics
- 14.22.1 Company Snapshot
- 14.22.2 Product Portfolio
- 14.22.3 Recent Developments
- 14.23 Phio Pharmaceuticals
- 14.23.1 Company Snapshot
- 14.23.2 Product Portfolio
- 14.23.3 Recent Developments
- 15 Questionnaire
- 16 Related Reports
- List Of Tables
- Table 1 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, Pipeline Analysis
- Table 2 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 3 Asia Pacific Nk Cell Therpaies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 4 Asia Pacific Nk Cell Directed Antibodies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 5 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 6 Asia Pacific Antibody-dependent Cell-mediated Cytotoxicity (Adcc) In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 7 Asia Pacific Bi-specific Antibodies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 8 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Application, 2019-2027 (Usd Million)
- Table 9 Asia Pacific Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 10 Asia Pacific Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 11 Asia Pacific Hematologic Malignancies In Cancer Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 12 Asia Pacific Others In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 13 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 14 Asia Pacific Hospitals In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 15 Asia Pacific Specialty Clinics In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 16 Asia Pacific Research And Academic Institutes In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 17 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2027 (Usd Million)
- Table 18 Asia Pacific Hospital Pharmacies In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2027 (Usd Million)
- Table 19 Asia Pacific Direct Tender In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2027 (Usd Million)
- Table 20 Asia Pacific Others In Natural Killer (Nk) Cell Therapeutics Market, By Region, 2018-2029 (Usd Million)
- Table 21 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By Country, 2018-2029 (Usd Million)
- Table 22 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 23 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 24 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 25 Asia-pacific Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 26 Asia-pacific Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 27 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 28 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 29 Japan Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 30 Japan Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 31 Japan Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 32 Japan Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 33 Japan Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 34 Japan Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 35 Japan Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 36 China Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 37 China Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 38 China Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 39 China Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 40 China Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 41 China Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 42 China Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 43 Australia Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 44 Australia Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 45 Australia Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 46 Australia Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 47 Australia Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 48 Australia Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 49 Australia Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 50 South Korea Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 51 South Korea Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 52 South Korea Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 53 South Korea Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 54 South Korea Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 55 South Korea Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 56 South Korea Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 57 India Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 58 India Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 59 India Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 60 India Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 61 India Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 62 India Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 63 India Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 64 Singapore Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 65 Singapore Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 66 Singapore Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 67 Singapore Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 68 Singapore Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 69 Singapore Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 70 Singapore Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 71 Malaysia Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 72 Malaysia Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 73 Malaysia Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 74 Malaysia Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 75 Malaysia Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 76 Malaysia Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 77 Malaysia Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 78 Thailand Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 79 Thailand Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 80 Thailand Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 81 Thailand Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 82 Thailand Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 83 Thailand Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 84 Thailand Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 85 Indonesia Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 86 Indonesia Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 87 Indonesia Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 88 Indonesia Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 89 Indonesia Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 90 Indonesia Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 91 Indonesia Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 92 Philippines Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 93 Philippines Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 94 Philippines Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 95 Philippines Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 96 Philippines Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 97 Philippines Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 98 Philippines Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 99 Vietnam Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- Table 100 Vietnam Natural Killer (Nk) Cell Therapeutics Market, By Approaches, 2018-2029 (Usd Million)
- Table 101 Vietnam Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 102 Vietnam Cancer In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 103 Vietnam Hematologic Malignancies In Natural Killer (Nk) Cell Therapeutics Market, By Application, 2018-2029 (Usd Million)
- Table 104 Vietnam Natural Killer (Nk) Cell Therapeutics Market, By End User, 2018-2029 (Usd Million)
- Table 105 Vietnam Natural Killer (Nk) Cell Therapeutics Market, By Distribution Channel, 2018-2029 (Usd Million)
- Table 106 Rest Of Asia- Pacific Natural Killer (Nk) Cell Therapeutics Market, By Therapeutics, 2018-2029 (Usd Million)
- List Of Figures
- Figure 1 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Segmentation
- Figure 2 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market : Data Triangulation
- Figure 3 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Droc Analysis
- Figure 4 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Asia Pacific Vs Regional Market Analysis
- Figure 5 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Company Research Analysis
- Figure 6 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Multivariate Modelling
- Figure 7 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Interview Demographics
- Figure 8 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Dbmr Market Position Grid
- Figure 9 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Vendor Share Analysis
- Figure 10 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Segmentation
- Figure 11 North America Is Expected To Dominate And Asia-pacific Is Growing With The Fastest Pace In The Asia Pacific Natural Killer (Nk) Cell Therapeutics Market In The Forecast Period Of 2022 To 2029
- Figure 12 Increase In Usage Of Natural Killer Cells For The Treatment Of Cancer And Infectious Diseases And Rise In The Awareness About Immunotherapies Is Driving The Asia Pacific Natural Killer (Nk) Cell Therapeutics Market In The Forecast Period Of 2022 To 2029
- Figure 13 Nk Cell Therapies Segment Is Expected To Account For The Largest Share Of The Asia Pacific Natural Killer (Nk) Cell Therapeutics Market In 2022 & 2029
- Figure 14 Asia-pacific Is The Fastest Growing Market For Natural Killer (Nk) Cell Therapeutics Manufacturers In The Forecast Period Of 2022 To 2029
- Figure 15 Drivers, Restraints, Opportunities, And Challenges Of Asia Pacific Natural Killer (Nk) Cell Therapeutics Market
- Figure 16 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, 2021
- Figure 17 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, 2022-2029 (Usd Million)
- Figure 18 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, Cagr (2022-2029)
- Figure 19 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics, Lifeline Curve
- Figure 20 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Approaches, 2021
- Figure 21 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Approaches, 2022-2029 (Usd Million)
- Figure 22 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Approaches, Cagr (2022-2029)
- Figure 23 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Approaches, Lifeline Curve
- Figure 24 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Application, 2020
- Figure 25 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Application, 2022-2029 (Usd Million)
- Figure 26 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Application, Cagr (2022-2029)
- Figure 27 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Application, Lifeline Curve
- Figure 28 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By End User, 2021
- Figure 29 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By End User, 2022-2029 (Usd Million)
- Figure 30 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By End User, Cagr (2022-2029)
- Figure 31 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By End User, Lifeline Curve
- Figure 32 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, 2021
- Figure 33 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, 2022-2029 (Usd Million)
- Figure 34 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, Cagr (2022-2029)
- Figure 35 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: By Distribution Channel, Lifeline Curve
- Figure 36 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market: Snapshot (2021)
- Figure 37 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market: By Country (2021)
- Figure 38 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market: By Country (2022 & 2029)
- Figure 39 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market: By Country (2021 & 2029)
- Figure 40 Asia-pacific Natural Killer (Nk) Cell Therapeutics Market: By Therapeutics (2022-2029)
- Figure 41 Asia Pacific Natural Killer (Nk) Cell Therapeutics Market: Company Share 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook